Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Biological Chemistry

RNA Recycling As An Antibiotic Plan

Stopping degradation of outdated RNA helps staph-infected mice survive

by Carmen Drahl
February 21, 2011 | A version of this story appeared in Volume 89, Issue 8

Molecules that interfere with RNA processing in bacterial cells might have potential as a new class of antibiotics, a study in mice suggests (PLoS Pathogens, DOI: 10.1371/
journal.ppat.1001287
). Microbes such as Staphylococcus aureus have developed resistance to many of medicine’s most powerful treatments, so researchers are hunting for drugs that work in different ways. The RNA-recycling process, which bacteria need to break down protein-making instructions that are no longer necessary and create new ones, has been considered a ripe target. But the enzyme players in gram-positive bacteria such as S. aureus aren’t clearly understood. Enter Paul M. Dunman of the University of Rochester and colleagues, who found that an essential bacterial protein called RnpA helps degrade those RNA instructions. They searched for inhibitors of RnpA and found RNPA1000, a molecule that blocks RnpA’s activity and helps mice survive S. aureus infection. Although the molecule is toxic to human cells at effective bacteria-killing concentrations, next-generation compounds may work better, the team says. They plan to use RNPA1000 to further probe RnpA’s role in infection.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.